There is a meta‐analysis showing that the association between anti‐TIF1‐γ antibody and malignant tumor complications had a sensitivity of 78%, a positive predictive value of 58%, and a negative predictive value of 95% [31]. This evidence concerns the gene TRIM33 and cancer.